Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2020 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Asset Writedowns and Impairment of $12.4 million in Q4 2025, up 1563.92% quarter-over-quarter from -$848000.0 in Q3 2025, and up 1199.56% on a YoY basis from $955248.5 in Q4 2024.

Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

Curaleaf Holdings' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $12.4 million for Q4 2025.

  • In Q4 2025, Asset Writedowns and Impairment rose 1199.56% year-over-year to $12.4 million; the TTM figure through Dec 2025 stood at $6.7 million (down 82.79% YoY), while the FY2025 annual figure was $9.1 million, up 2093.24% from the prior year.
  • Asset Writedowns and Impairment was $12.4 million for Q4 2025 at Curaleaf Holdings, up from -$848000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $65.7 million in Q4 2023 to a low of -$144.5 million in Q4 2022.
  • Historically, Asset Writedowns and Impairment has averaged -$9.4 million across 5 years, with a median of -$988500.0 in 2024.
  • The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment sank 1670.23% in 2022, then surged 1199.56% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $9.2 million in 2021, then tumbled by 1670.23% to -$144.5 million in 2022, then surged by 145.5% to $65.7 million in 2023, then tumbled by 101.72% to -$1.1 million in 2024, then soared by 1199.56% to $12.4 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $12.4 million (Q4 2025), -$848000.0 (Q3 2025), and -$3.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 12.41 Mn
Dec 31, 2025 12.41 Mn
Sep 30, 2025 -848,000.00
Sep 30, 2025 -848,000.00
Mar 31, 2025 -3.70 Mn
Mar 31, 2025 -3.70 Mn
Dec 31, 2024 -1.13 Mn
Dec 31, 2024 -1.13 Mn
Sep 30, 2024 -642,000.00
Sep 30, 2024 -642,000.00
Dec 31, 2023 65.73 Mn
Dec 31, 2023 65.73 Mn
Sep 30, 2023 -24.79 Mn
Sep 30, 2023 -24.79 Mn
Dec 31, 2022 -144.46 Mn
Dec 31, 2022 -144.46 Mn
Dec 31, 2021 9.20 Mn
Dec 31, 2021 9.20 Mn
Sep 30, 2021 -5.67 Mn
Sep 30, 2021 -5.67 Mn